TY - JOUR
T1 - Facile Chemical Strategy to Hydrophobically Modify Solid Nanoparticles Using Inverted Micelle-Based Multicapsule for Efficient Intracellular Delivery
AU - Daza, Enrique A.
AU - Schwartz-Duval, Aaron S.
AU - Volkman, Kimberly
AU - Pan, Dipanjan
N1 - Funding Information:
The authors acknowledge financial support from the University of Illinois at Urbana−Champaign, the Institute for Sustainability, Energy, and Environment, and the Children’s Discovery Institute. The Authors would like to acknowledge Santosh K. Misra for technical input. TEM, FTIR, RAMAN, UV−vis, and zeta potential measurements were carried out in part in the Frederick Seitz Materials Research Laboratory Central Research Facilities, University of Illinois. We thank Kiran Subedi for performing ICP-OES at the Noyes Microanalysis Laboratory, John Scott of the Illinois Sustainable Technology Center for fluorescent characterization, and Lou Ann Miller for cellular TEM sample preparation.
Publisher Copyright:
© 2018 American Chemical Society.
PY - 2018/4/9
Y1 - 2018/4/9
N2 - Theranostic nanoparticles have incredible potential for biomedical applications by enabling visual confirmation of therapeutic efficacy. Numerous issues challenge their clinical translation and are primarily related to the complex chemistry and scalability of synthesizing Nanoparticles. We report a 2-step chemical strategy for high-throughput intracellular delivery of organic and inorganic solid nanoparticles. This process takes an additional step beyond hydrophobic surface modification facilitated by inverted micelle transfer, toward the packing of multiple solid nanoparticles into a soft-shelled lipid capsule, termed the Nano-multicapsule (NMC). This technique is high yielding and does not require the complex purification steps in anaerobic/hydrophobic reactions for hydrophobic modification. To demonstrate the efficacy across different material compositions, we separately entrapped ∼10 nm gold and carbon nanoparticles (AuNP and CNP) within inverted micelles, and subsequently NMCs, then quantified their internalization in a human breast cancer cell line. For encapsulated AuNPs (NMC-AuNP), we confirmed greater cellular internalization of gold through ICP-OES and TEM analyses. Raman spectroscopic analysis of cells treated with encapsulated CNPs (NMC-CNP) also exhibited high degrees of uptake with apparent intracellular localization as opposed to free CNP treatment.
AB - Theranostic nanoparticles have incredible potential for biomedical applications by enabling visual confirmation of therapeutic efficacy. Numerous issues challenge their clinical translation and are primarily related to the complex chemistry and scalability of synthesizing Nanoparticles. We report a 2-step chemical strategy for high-throughput intracellular delivery of organic and inorganic solid nanoparticles. This process takes an additional step beyond hydrophobic surface modification facilitated by inverted micelle transfer, toward the packing of multiple solid nanoparticles into a soft-shelled lipid capsule, termed the Nano-multicapsule (NMC). This technique is high yielding and does not require the complex purification steps in anaerobic/hydrophobic reactions for hydrophobic modification. To demonstrate the efficacy across different material compositions, we separately entrapped ∼10 nm gold and carbon nanoparticles (AuNP and CNP) within inverted micelles, and subsequently NMCs, then quantified their internalization in a human breast cancer cell line. For encapsulated AuNPs (NMC-AuNP), we confirmed greater cellular internalization of gold through ICP-OES and TEM analyses. Raman spectroscopic analysis of cells treated with encapsulated CNPs (NMC-CNP) also exhibited high degrees of uptake with apparent intracellular localization as opposed to free CNP treatment.
UR - http://www.scopus.com/inward/record.url?scp=85045188012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045188012&partnerID=8YFLogxK
U2 - 10.1021/acsbiomaterials.8b00061
DO - 10.1021/acsbiomaterials.8b00061
M3 - Article
AN - SCOPUS:85045188012
SN - 2373-9878
VL - 4
SP - 1357
EP - 1367
JO - ACS Biomaterials Science and Engineering
JF - ACS Biomaterials Science and Engineering
IS - 4
ER -